ProJenX, Inc.
PrivateLast Round
Grant
Jun 20, 2024
Total Funding Raised
$21.1M
Company Overview
ProJenX, Inc. operates in Healthcare & Life Sciences and is based in Nissequogue, New York. Its latest recorded funding round was a Grant round in June 2024.
ProJenX, Inc. is a biotechnology company that develops novel, brain-penetrant, targeted therapies for the treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProJenX, Inc. Comparables
Compare ProJenX, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QurAlis | 84% | |
| Trace Neuroscience | 82% | |
| Spinogenix, Inc. | 82% |
For institutional investors. Book with your work email.
ProJenX, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 20, 2024 | ||||
| Series A | Nov 2, 2023 | ||||
| Seed | Feb 16, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ProJenX, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| Medical Excellence Capital | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2024
$1M grant received from The ALS Association.
For institutional investors. Book with your work email.
ProJenX, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ProJenX, Inc.'s valuation, stock price, and market status.
Is ProJenX, Inc. a public or private company?
ProJenX, Inc. is a private company.
What is the current stock price of ProJenX, Inc.?
ProJenX, Inc. is a private company, so its shares have no public market price. Caplight tracks ProJenX, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ProJenX, Inc. worth (valuation)?
Valuation information for ProJenX, Inc. is not publicly available.
Can I buy ProJenX, Inc. stock?
ProJenX, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ProJenX, Inc.'s last funding round?
ProJenX, Inc.'s most recent funding round was Grant on June 20, 2024.
Who are the main investors in ProJenX, Inc.?
Key investors in ProJenX, Inc. include Medical Excellence Capital.
Will ProJenX, Inc. IPO soon?
No public IPO plans have been announced for ProJenX, Inc..
How can I track ProJenX, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in ProJenX, Inc.'s shares on secondary markets.